Equities research analysts expect that HealthSouth Corporation (NYSE:HLS) will announce $986.71 million in sales for the current fiscal quarter, according to Zacks. Five analysts have issued estimates for HealthSouth Corporation’s earnings, with estimates ranging from $980.84 million to $993.50 million. HealthSouth Corporation posted sales of $926.80 million during the same quarter last year, which suggests a positive year-over-year growth rate of 6.5%. The business is scheduled to issue its next quarterly earnings results on Thursday, October 26th.

According to Zacks, analysts expect that HealthSouth Corporation will report full-year sales of $986.71 million for the current financial year, with estimates ranging from $3.90 billion to $3.96 billion. For the next fiscal year, analysts expect that the business will report sales of $4.17 billion per share, with estimates ranging from $4.11 billion to $4.21 billion. Zacks’ sales calculations are an average based on a survey of research analysts that that provide coverage for HealthSouth Corporation.

HealthSouth Corporation (NYSE:HLS) last issued its quarterly earnings results on Monday, July 31st. The company reported $0.71 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $0.68 by $0.03. HealthSouth Corporation had a return on equity of 25.07% and a net margin of 6.70%. The firm had revenue of $981.30 million during the quarter, compared to analyst estimates of $976.46 million. During the same quarter in the previous year, the company posted $0.69 earnings per share. The company’s revenue was up 6.6% compared to the same quarter last year.

Several research analysts have commented on the stock. Mizuho increased their price objective on shares of HealthSouth Corporation from $44.00 to $47.00 and gave the company a “neutral” rating in a report on Monday, July 10th. BidaskClub downgraded shares of HealthSouth Corporation from a “hold” rating to a “sell” rating in a report on Thursday, July 13th. KeyCorp reissued a “hold” rating on shares of HealthSouth Corporation in a report on Thursday. Zacks Investment Research downgraded shares of HealthSouth Corporation from a “buy” rating to a “hold” rating in a report on Monday, July 3rd. Finally, ValuEngine downgraded shares of HealthSouth Corporation from a “buy” rating to a “hold” rating in a report on Friday, June 2nd. Two research analysts have rated the stock with a sell rating, five have given a hold rating and four have given a buy rating to the company. HealthSouth Corporation presently has an average rating of “Hold” and a consensus price target of $49.71.

In related news, CEO Mark J. Tarr sold 22,625 shares of the stock in a transaction dated Thursday, August 3rd. The shares were sold at an average price of $42.55, for a total value of $962,693.75. Following the completion of the transaction, the chief executive officer now owns 283,134 shares of the company’s stock, valued at approximately $12,047,351.70. The sale was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. 1.60% of the stock is currently owned by company insiders.

Large investors have recently made changes to their positions in the stock. Mackay Shields LLC bought a new position in shares of HealthSouth Corporation in the 2nd quarter valued at about $39,641,000. American International Group Inc. lifted its holdings in shares of HealthSouth Corporation by 3.4% in the 1st quarter. American International Group Inc. now owns 229,244 shares of the company’s stock valued at $9,814,000 after acquiring an additional 7,579 shares during the last quarter. Aviva PLC lifted its holdings in shares of HealthSouth Corporation by 67.5% in the 2nd quarter. Aviva PLC now owns 43,670 shares of the company’s stock valued at $2,133,000 after acquiring an additional 17,600 shares during the last quarter. Renaissance Technologies LLC lifted its holdings in shares of HealthSouth Corporation by 83.6% in the 1st quarter. Renaissance Technologies LLC now owns 710,200 shares of the company’s stock valued at $30,404,000 after acquiring an additional 323,300 shares during the last quarter. Finally, Investec Asset Management LTD lifted its holdings in shares of HealthSouth Corporation by 4.6% in the 1st quarter. Investec Asset Management LTD now owns 226,365 shares of the company’s stock valued at $9,691,000 after acquiring an additional 10,000 shares during the last quarter. 93.10% of the stock is owned by hedge funds and other institutional investors.

Shares of HealthSouth Corporation (NYSE:HLS) opened at 44.73 on Monday. The company has a market cap of $4.42 billion, a price-to-earnings ratio of 16.30 and a beta of 0.59. The firm’s 50-day moving average price is $44.10 and its 200 day moving average price is $44.79. HealthSouth Corporation has a 52 week low of $36.97 and a 52 week high of $49.71.

The firm also recently declared a quarterly dividend, which will be paid on Monday, October 16th. Investors of record on Monday, October 2nd will be issued a $0.25 dividend. This is an increase from HealthSouth Corporation’s previous quarterly dividend of $0.24. The ex-dividend date is Friday, September 29th. This represents a $1.00 dividend on an annualized basis and a dividend yield of 2.24%. HealthSouth Corporation’s dividend payout ratio (DPR) is presently 35.29%.

WARNING: This news story was first reported by The Cerbat Gem and is the property of of The Cerbat Gem. If you are reading this news story on another site, it was illegally copied and reposted in violation of US and international trademark & copyright laws. The correct version of this news story can be viewed at https://www.thecerbatgem.com/2017/09/11/healthsouth-corporation-hls-expected-to-announce-quarterly-sales-of-986-71-million.html.

About HealthSouth Corporation

HealthSouth Corporation (HealthSouth) is a provider of post-acute healthcare services, offering both facility-based and home-based post-acute services in 35 states and Puerto Rico through its network of inpatient rehabilitation hospitals, home health agencies and hospice agencies. The Company manages its operations through segments, including inpatient rehabilitation, and home health and hospice.

Get a free copy of the Zacks research report on HealthSouth Corporation (HLS)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for HealthSouth Corporation (NYSE:HLS)

Receive News & Stock Ratings for HealthSouth Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HealthSouth Corporation and related stocks with our FREE daily email newsletter.